반응식
[C:1]([C:3]1[CH:8]=[CH:7][C:6]([N:9]=[C:10]2[S:14][CH2:13][C:12]3([CH2:18][CH2:17][CH2:16][CH2:15]3)[NH:11]2)=[C:5]([CH2:19][CH3:20])[CH:4]=1)#[N:2].Br[CH:22]([CH2:25][CH3:26])[CH2:23][CH3:24]>>[C:1]([C:3]1[CH:8]=[CH:7][C:6]([N:9]=[C:10]2[S:14][CH2:13][C:12]3([CH2:15][CH2:16][CH2:17][CH2:18]3)[N:11]2[CH:22]([CH2:25][CH3:26])[CH2:23][CH3:24])=[C:5]([CH2:19][CH3:20])[CH:4]=1)#[N:2]참가 물질
3
실험 절차
1-Hydroxymethylcyclopentanamine was prepared according to Method B1c. The 2-hydroxyethylamine was converted to 1-chloromethylcyclopentanamine HCl salt according to Method B7e. 1-Chloromethylcyclopentanamine HCl salt was reacted with 4-cyano-2-ethylphenyl isothiocyanate according to Method C1e to give 2-(4-cyano-2-ethylphenylimino)-3-thia-1-azaspiro[4.4]nonane. The thiazolidine was reacted with 3-bromopentane according to Method D2b to give 2-(4-cyano-2-ethylphenylimino)-1-(3-pentyl)-3-thia-1-azaspiro[4.4]nonane.
출처 및 근거
- ORD 기록
- ord-99b15b0472434bb480ff2bf0ee467872
- 출처 데이터셋
- uspto-grants-2002_03
- 특허 번호
- US06353006B1
연결된 노트
불러오는 중…